Title | Pharmacogenetics and Genomics |
Abbreviation | Pharmacogenetics Genom. |
Publication Type | Journal |
Subject Area, Categories, Scope | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3) |
h-index | 152 |
Overall Rank/Ranking | 9602 |
SCImago Journal Rank (SJR) | 0.563 |
Impact Score | 1.94 |
Publisher | Lippincott Williams and Wilkins Ltd. |
Country | United States |
ISSN | 17446880, 17446872 |
Best Quartile | Q1 |
Coverage History | 2005-2023 |
Pharmacogenetics and Genomics is devoted to the rapid publication of research papers, brief review articles and short communications on genetic determinants in response to drugs and other chemicals in humans and animals. The Journal brings together papers from the entire spectrum of biomedical research and science, including biochemistry, bioinformatics, clinical pharmacology, clinical pharmacy, epidemiology, genetics, genomics, molecular biology, pharmacology, pharmaceutical sciences, and toxicology. Under a single cover, the Journal provides a forum for all aspects of the genetics and genomics of host response to exogenous chemicals: from the gene to the clinic.
Pharmacogenetics and Genomics is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of Pharmacogenetics and Genomics is 9602. According to SCImago Journal Rank (SJR), this journal is ranked 0.563. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 152. The best quartile for this journal is Q1.
The ISSN of Pharmacogenetics and Genomics journal is 17446880, 17446872. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pharmacogenetics and Genomics is cited by a total of 208 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Pharmacogenetics and Genomics is 1.94, which is computed in 2024 as per its definition. Pharmacogenetics and Genomics IF is decreased by a factor of 0.6 and approximate percentage change is -23.62% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Pharmacogenetics and Genomics is 1.94. If the same downward trend persists, Impact IF may fall in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 1.94 |
2022 | 2.54 |
2021 | 1.80 |
2020 | 1.56 |
2019 | 2.62 |
2018 | 3.00 |
2017 | 2.54 |
2016 | 2.35 |
2015 | 3.20 |
2014 | 3.84 |
Pharmacogenetics and Genomics has an h-index of 152. It means 152 articles of this journal have more than 152 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Pharmacogenetics and Genomics is 17446880, 17446872. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Pharmacogenetics and Genomics is 9602. According to SCImago Journal Rank (SJR), this journal is ranked 0.563. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.563 |
2022 | 0.486 |
2021 | 0.385 |
2020 | 0.579 |
2019 | 0.774 |
2018 | 0.808 |
2017 | 0.933 |
2016 | 1.009 |
2015 | 1.254 |
2014 | 1.343 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 9602 |
2022 | 10597 |
2021 | 12433 |
2020 | 8732 |
2019 | 6173 |
2018 | 5837 |
2017 | 4799 |
2016 | 4375 |
2015 | 3187 |
2014 | 2758 |
Pharmacogenetics and Genomics is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 2005-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Pharmacogenetics and Genomics is Pharmacogenetics Genom.. This abbreviation ('Pharmacogenetics Genom.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Pharmacogenetics and Genomics latest impact IF is 1.94. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.84 (2014) and 1.56 (2020), respectively, in the last 10 years. Moreover, its average IS is 2.54 in the previous 10 years.
The Pharmacogenetics and Genomics has an SJR (SCImago Journal Rank) of 0.563, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.343 in 2014 and the lowest being 0.385 in 2021. Furthermore, the average SJR of the Pharmacogenetics and Genomics over the previous 10-year period stands at 2.54.
The latest h-index of the Pharmacogenetics and Genomics is 152.
The Pharmacogenetics and Genomics is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.
The Pharmacogenetics and Genomics is currently ranked 9602 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2758 in 2014 and its lowest position of 12433 in 2021.
The standard ISO4 abbreviation for the Pharmacogenetics and Genomics is Pharmacogenetics Genom..
Pharmacogenetics and Genomics is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.
The Pharmacogenetics and Genomics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Pharmacogenetics and Genomics is assigned the following International Standard Serial Numbers (ISSN): 17446880, 17446872.
The best quartile for the Pharmacogenetics and Genomics is Q1 (2023).
The Pharmacogenetics and Genomics coverage history can be summarized as follows: 2005-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
Journal of International Financial Management and Accounting | journal | 1921 | Wiley-Blackwell Publishing Ltd | 45 | 9.38 |
Journal of Supply Chain Management | journal | 587 | Wiley-Blackwell | 112 | 12.51 |
Journal of Classical Sociology | journal | 15798 | SAGE Publications Ltd | 30 | 1.30 |
Palaeontographica Abteilung B: Palaeophytologie | book series | 10391 | E. Schweizerbart'sche Verlagsbuchhandlung | 17 | 3.43 |
Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
Oral Radiology | journal | 8912 | Springer Japan | 23 | 2.13 |
Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 1.94 |
2022 | 2.54 |
2021 | 1.80 |
2020 | 1.56 |
2019 | 2.62 |
2018 | 3.00 |
2017 | 2.54 |
2016 | 2.35 |
2015 | 3.20 |
2014 | 3.84 |